Page URL:

Removing single gene prevents aggressive pancreatic cancer in mice

7 May 2019
Appeared in BioNews 997

Researchers have discovered that the deletion of a single gene can halt the development and progression of aggressive pancreatic cancer in mice.

Deleting a gene called ATDC in mice eliminated pancreatic adenocarcinoma – one of the most aggressive pancreatic cancers.

Senior study author Dr Diane Simeone, director of the Pancreatic Cancer Centre at New York University's Langone Health, said that her team had thought the deletion of ATDC would slow cancer growth, but would not halt its development.

'We found that deleting the ATDC gene in pancreatic cells resulted in one of the most profound blocks of tumour formation ever observed in a well-known mice model engineered to develop pancreatic ductal adenocarcinoma, or PDA, which faithfully mimics the human disease,' she said.

Mutations in the gene KRAS are present in over 90 percent of aggressive PDAs. In this study, 100 percent of mice with a mutated KRAS gene and an active ATDC gene developed cancer. However, none of the mice with a mutated KRAS gene but the ATDC gene removed developed cancer.

In PDA, cells within the pancreas that secrete digestive enzymes into the small intestine, known as acinar cells, can revert to a primitive stem-cell-like state to aid injury and inflammation. If there are mutations in certain genes, such as KRAS, these cells can become cancerous. In the mice without the ATDC gene, the acinar cells' transformation into cancerous cells was cut short early on in the process, the researchers found. 

PDA is one of the worst-prognosis malignant cancers in humans. It is set to become the second-leading cause of cancer death in the USA by 2030.

The research was published in the journal Genes and Development.

ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis
Genes and Development |  2 May 2019
Deleting just one gene may 'completely prevent' pancreatic cancer
Medical News Today |  2 May 2019
Pancreatic Cancer Halted in Mice Through Single Gene Deletion
Genetic Engineering and Biotechnology News |  2 May 2019
Removal of Gene Completely Prevents Development of Aggressive Pancreatic Cancer in Mice
NYU Langone Health |  2 May 2019
22 July 2019 - by Dr Yvonne Collins 
Researchers have identified a gene, active in the early stages of development, that may help conceal cancers from common immunotherapy treatment...
1 July 2019 - by Dr James Heather 
More than 150 researchers have backed a letter written by senior scientists protesting the move to close one of the UK’s leading mouse-genetics centres at the Harwell Institute in Oxfordshire...
15 April 2019 - by Charlotte Spicer 
UK scientists have used genome-editing to identify hundreds of potential drug targets for new cancer treatments...
18 March 2019 - by Catherine Heffner 
A woman's risk of developing cancer is up to one fifth higher for those with fertility issues compared with those without these problems, according to new research...
28 January 2019 - by Martha Henriques 
The US Food and Drug Administration has approved a direct-to-consumer genetic test for a hereditary form of colorectal cancer by 23andMe...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.